EHU037801
MISSION® esiRNA
targeting human MYO10
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.51
UNSPSC Code:
41105324
description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
ACAGCAGGATCAAAGGCAATGAGGACTTCAAGTCTATTGGCATCCTCGACATCTTTGGATTTGAAAACTTTGAGGTTAATCACTTTGAACAGTTCAATATAAACTATGCAAACGAGAAACTTCAGGAGTACTTCAACAAGCATATTTTTTCTTTAGAACAACTAGAATATAGCCGGGAAGGATTAGTGTGGGAAGATATTGACTGGATAGACAATGGAGAATGCCTGGACTTGATTGAGAAGAAACTTGGCCTCCTAGCCCTTATCAATGAAGAAAGCCATTTTCCTCAAGCCACAGACAGCACCTTATTGGAGAAGCTACACAGTCAGCATGCGAATAACCACTTTTATGTGAAGCCCAGAGTTGCAGTTAACAATTTTGGAGTGAAGCACTATGCTGGAGAGGTGCA
Ensembl | human accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
human ... MYO10(4651)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
Storage Class
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Jaime Uhl et al.
Journal of cell communication and signaling, 13(2), 209-224 (2018-11-18)
Tunneling nanotubes (TNTs) are intercellular structures that allow for the passage of vesicles, organelles, genomic material, pathogenic proteins and pathogens. The unconventional actin molecular motor protein Myosin-X (Myo10) is a known inducer of TNTs in neuronal cells, yet its role
Emily R Summerbell et al.
Science advances, 6(30), eaaz6197-eaaz6197 (2020-08-25)
Tumor heterogeneity drives disease progression, treatment resistance, and patient relapse, yet remains largely underexplored in invasion and metastasis. Here, we investigated heterogeneity within collective cancer invasion by integrating DNA methylation and gene expression analysis in rare purified lung cancer leader
Global Trade Item Number
| SKU | GTIN |
|---|---|
| EHU037801-50UG | 04061828312993 |
| EHU037801-20UG | 04061831341584 |